As of 2026-03-26, the Relative Valuation of Constellation Pharmaceuticals Inc (CNST) is (68.11) USD. This relative valuation is based on P/E multiples. With the latest stock price at 33.99 USD, the upside of Constellation Pharmaceuticals Inc based on Relative Valuation is -300.4%.
The range of the Relative Valuation is (64.20) - (74.85) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 21.8x - 27.0x | 24.4x |
| Forward P/E multiples | 21.1x - 25.4x | 21.9x |
| Fair Price | (64.20) - (74.85) | (68.11) |
| Upside | -288.9% - -320.2% | -300.4% |
| Date | P/E |